SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-284583
Filing Date
2022-11-14
Accepted
2022-11-14 16:15:40
Documents
58
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d383755d10q.htm   iXBRL 10-Q 1143950
2 EX-31.1 d383755dex311.htm EX-31.1 10546
3 EX-31.2 d383755dex312.htm EX-31.2 10916
4 EX-32.1 d383755dex321.htm EX-32.1 4745
5 EX-32.2 d383755dex322.htm EX-32.2 4715
  Complete submission text file 0001193125-22-284583.txt   5031926

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA abos-20220930.xsd EX-101.SCH 45643
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abos-20220930_cal.xml EX-101.CAL 38191
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abos-20220930_def.xml EX-101.DEF 217468
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE abos-20220930_lab.xml EX-101.LAB 324244
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abos-20220930_pre.xml EX-101.PRE 271717
52 EXTRACTED XBRL INSTANCE DOCUMENT d383755d10q_htm.xml XML 805064
Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Filer) CIK: 0001576885 (see all company filings)

IRS No.: 364108129 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40551 | Film No.: 221385551
SIC: 2836 Biological Products, (No Diagnostic Substances)